TY  - JOUR

T1  - Evaluation of the molecular mechanisms for the sequence-dependent, synergistic anti-tumour effects of doxorubicin and zoledronic acid in breast cancer.

JO  - Cancer Research

UR  - https://doi.org/10.1158/0008-5472.sabcs-2151

PY  - 2009/01/15

AU  - Ottewell PD

AU  - Lefley DV

AU  - Coleman RE

AU  - Holen I

ED  - 

DO  - DOI: 10.1158/0008-5472.sabcs-2151

PB  - American Association for Cancer Research (AACR)

VL  - 69

IS  - 2_Supplement

SP  - 2151

EP  - 2151

Y2  - 2025/11/04

ER  -